World leading researchers
Professor Richard Beasley
Professor Beasley is the Director of the Medical Research Institute of New Zealand (MRINZ). He is from Wellington, New Zealand and is a world expert on asthma and asthma clinical trials. He has an Honorary Fellowship of London’s Royal College of Physicians for his outstanding work in asthma and in communication with patients.
In 2011, product development company, Locus Research, and Christchurch based The Merino Company won the Medical Design Excellence Award (MDEA) in the United States for their range of merino wool compression garments designed and developed in New Zealand. Professor Richard Beasley, in his role as Director of the MRINZ, led the research team which tested the garments. The MDEA recognise the achievements of medical product manufacturers, engineers, designers and clinicians who are responsible for groundbreaking innovations that “change the face of healthcare”. The compression garments, ‘Encircle Compression Therapy’, were developed for The Merino Company (TMC) by a crack Kiwi team led by Locus Research, partnered with the AgResearch Textiles Group and the Medical Research Institute of New Zealand. The project was co funded and supported by the New Zealand Ministry of Science and Innovation (MSI).
Professor Ed Gane
Ed Gane is Professor of Medicine at the University of Auckland, New Zealand and Deputy Director of the New Zealand Liver Transplant Unit at Auckland City Hospital.
Prof Gane trained in hepatology and completed his MD on the pathogenesis of hepatitis C-related liver injury. In 1996, Ed was appointed Transplant Physician for the first New Zealand Liver Transplant programme. In addition, he runs the National Hepatoma Clinic as well as hepatitis clinics at both Auckland and Greenlane Hospitals.
Ed has been the Government Clinical Advisor to the National Hepatitis B Screening Programme since its inception in 1998 and is now Clinical Advisor for the Ministry of Health Hepatitis C Project. In 2011, Ed received the Member of Order of New Zealand for Services to Hepatology and Transplantation. He is an investigator for many international clinical trials of therapies for chronic HBV, HCV, and hepatocellular carcinoma including phase I studies of new molecular agents. Ed has published over 100 papers in peer-reviewed journals including The Lancet and The New England Journal of Medicine and serves on the editorial committee for several journals.